MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients suffering from debilitating central nervous system disorders (CNS). Its lead product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist, ML-007, co-formulated with a peripherally acting anticholinergic (PAC), which it is initially developing for the treatment of schizophrenia and Alzheimer’s disease psychosis (ADP). ML-007C-MA is designed to activate both M1 and M4 muscarinic receptors in the CNS to drive efficacy, while synchronizing the pharmacokinetics of the agonist and antagonist components to mitigate peripheral cholinergic side effects. Its second product candidate, ML-004, is a 5-HT1B/1D agonist that the Company is developing for the treatment of social communication deficit and/or irritability in autism spectrum disorder. It is also advancing two preclinical programs, ML-021 and ML-009. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MPLT | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MPLT | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
MapLight Therapeutics Inc. (MPLT) share price today is $13.81
Yes, Indians can buy shares of MapLight Therapeutics Inc. (MPLT) on Vested. To buy MapLight Therapeutics Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MPLT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of MapLight Therapeutics Inc. (MPLT) via the Vested app. You can start investing in MapLight Therapeutics Inc. (MPLT) with a minimum investment of $1.
You can invest in shares of MapLight Therapeutics Inc. (MPLT) via Vested in three simple steps:
The price-to-book (P/B) ratio of MapLight Therapeutics Inc. (MPLT) is 0.00
The market capitalization of MapLight Therapeutics Inc. (MPLT) is $637.16M
The stock symbol (or ticker) of MapLight Therapeutics Inc. is MPLT
Link copied
